Teijin Ltd. engages in the management of its group companies that are involved in the environment and energy, safety and protection, information and electronics, transportation, and healthcare businesses. It operates through the following segments: Materials, Healthcare, and Others. The Materials segment handles the manufacture and sale of polyester, aramid, and carbon fiber products as well as plastic and resin products from polycarbonate resin and polyester film. The Healthcare segment deals with the manufacture and sale of pharmaceuticals and home medical equipment. It also provides home healthcare services. The Others segment offers information technology services. The company was founded by Seita Kumura, Itsuzo Hata, and Naokichi Kaneko on June 17, 1918 and is headquartered in Osaka, Japan.

UAB Research Foundation (doing business as UABRF), a subsidiary of The University of Alabama System, is a company headquartered in Birmingham, AL. The firm engages in identify, assess, and market commercially viable technology developed at The University of Alabama at Birmingham.

Part of Takeda Pharmaceutical Co., Ltd., Takeda GmbH is a company headquartered in Konstanz, Germany, that manufactures pharmaceutical products. The firm was founded in 1873. Wolfgang Eck, Uwe Hoffmeister and Roland Kurney are the current co-CEOs of the company.

Tokyo Tanabe Co. Ltd., a subsidiary of Cegedim SA, is a Japanese company located in Tokyo. The firm produces and sells medicines.

Scios Inc. is a pharmaceutical company developing drugs for the treatment of cardiovascular and inflammatory diseases. The company is a subsidiary of Johnson & Johnson. The company’s portfolio of drugs includes NatrecorO, a promising drug for heart failure. Scios Inc. was founded in 1981 and is based in California.

ALTANA Pharma AG develops and manufactures pharmaceuticals. It provides services in the areas of therapeutics, imaging and OTC medication. The company is headquartered in Konstanz, Germany.

Uhde, a subsidiary of thyssenkrupp AG, is a German company that provides chemical engineering services. Krupp Hoesch AG acquired Uhde from Hoechst AG on January 01, 1996 for $482.09 million.

Nanjing Zhikun Environmental Protection Technology Co., Ltd., established on 2016-08-29, Business scope includes research and development of environmental protection technology;Research and development of liquid filtration machinery,manufacture,Sales,Install;Research and development of special equipment for environmental protection,processing,Sales,Install;Environmental Engineering Design,construction;Research and development of industrial automatic control system devices,manufacture,Technical Services;Biological Technology,Chemical technology research and development,technology transfer;Electrical Equipment,hardware,Instrumentation,valve,Computer hardware and software,Computer Network Equipment Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

PAKA Pulmonary Pharmaceuticals, Inc. is a private company headquartered in Acton, MA, that designs and manufactures drugs for lung diseases.

Kotobuki Pharmaceutical Co.,Ltd., develops and manufactures drugs and medical supplies. It offers various prescription drugs, such as tablets, granules, creams, capsules, combination tablets, solutions, generic drugs, gastritis, gastric ulcer, and duodenal ulcer therapeutic agents. It also offer antihypertensive agents, Type 2 diabetes therapeutic agents, and cholesterol absorption inhibitors. The company was founded in 1949 and is based in Hanishina, Japan.

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Shanghai Fudan Fuhua Pharmaceutical Co., Ltd., established on 1981-12-01, The business scope includes freeze-dried powder injection,tablet(Contains antineoplastic drugs),hard capsule,API,Chinese medicine extraction workshop,Engaged in technology development in the field of medicine,technical consulting,Technical Services,technology transfer,wholesale(non-physical means):Pre-packaged food(Does not contain cooked food lo mei,Refrigerated).[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada.

China Resources Double-Crane Pharmaceutical Co., Ltd. engages in the processing, manufacture, and sale of pharmaceutical, chemical, and biomedical raw materials. It operates through the following business segments: Infusion and Non-infusion. Its products include compound reserpine flattamine tablets, amlodipine besylate tablets, gliquidone tablets, citicoline sodium tablets, magnesium valproate sustained-release tablets, and soft bags. The company was founded on May 16, 1997 and is headquartered in Beijing, China.

Tianjin Zhengjiang High-tech Co., Ltd., established on 1995-05-04, Business scope includes technology development,consult,Serve,transfer[new material,biology(except medicines)Technology and Products].

Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals. Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals.” In accordance with this philosophy, as we implement our business activities we strive to realize our vision, which expresses that “Mitsubishi Tanabe Pharma strive to be a global research-driven pharmaceutical company that is trusted by communities.” As a company that is trusted and highly evaluated by patients and health care professionals as well as by society and shareholders, we will implement management with a focus on transparency and fairness while always keeping in mind the starting point of our business activities: “Everything we do is for the patients.”

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.